ROYALTY PHARMA PLC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$67.18
+1.90%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+16.6%
3 months
+18.0%
6 months
+37.0%
1 year
+85.4%
Year to date
+76.3%
52-week range
$36.24 – $67.18
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$38.63B
P/E
47.4
P/B
3.9
P/S
15.2
Revenue
$2.54B
Net income
$815M
Diluted EPS
1.88
Gross margin
100.00%
Net margin
32.10%
Return on equity
8.30%
Total debt
$8.96B
Cash
$811.99M
Free cash flow
$2.92B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $674.14M | $17.88M | 100.00% | 2.70% | $728.46M |
| Mar 31, 2026 | $630.58M | $294.69M | 100.00% | 46.70% | $668.23M |
| Dec 31, 2025 | $621.99M | $214.21M | 100.00% | 34.40% | $824.44M |
| Sep 30, 2025 | $609.29M | $288.22M | 100.00% | 47.30% | $702.62M |
| Jun 30, 2025 | $578.67M | $30.18M | 100.00% | 5.20% | $145.38M |
| Mar 31, 2025 | $568.25M | $238.35M | 100.00% | 41.90% | $546.08M |
| Dec 31, 2024 | $593.64M | $208.21M | 100.00% | 35.10% | $717.53M |
| Sep 30, 2024 | $564.69M | $543.99M | 100.00% | 96.30% | $703.61M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent RPRX news
All market newsNo ticker-linked stories are in the current archive.